Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EUF | Ann: EUF NTA 29-07-2025 $2.59667 | 08:02 | 0 | 28 | |||
|
|||||||
EUF | Ann: EUF NTA 28-07-2025 $2.63228 | 29/07/25 | 0 | 58 | |||
|
|||||||
EUF | Ann: EUF NTA 25-07-2025 $2.61116 | 28/07/25 | 0 | 49 | |||
|
|||||||
EUF | Ann: EUF NTA 24-07-2025 $2.64238 | 25/07/25 | 0 | 43 | |||
|
|||||||
EUF | Ann: EUF NTA 23-07-2025 $2.61119 | 24/07/25 | 0 | 62 | |||
|
|||||||
EUF | Ann: EUF NTA 22-07-2025 $2.60245 | 23/07/25 | 0 | 60 | |||
|
|||||||
EUF | Ann: EUF NTA 21-07-2025 $2.59049 | 22/07/25 | 0 | 51 | |||
|
|||||||
EUF | Ann: EUF NTA 18-07-2025 $2.61753 | 21/07/25 | 0 | 76 | |||
|
See All Discussions